202 related articles for article (PubMed ID: 24228933)
1. Managing HIV/hepatitis C co-infection in the era of direct acting antivirals.
Rockstroh JK; Bhagani S
BMC Med; 2013 Nov; 11():234. PubMed ID: 24228933
[TBL] [Abstract][Full Text] [Related]
2. Antiviral therapy for HCV in hemophilia A patients with HIV-1 co-infection.
Xiao H; Chen J; Wang J; Li J; Yang F; Lu H
Medicine (Baltimore); 2019 Jul; 98(30):e16524. PubMed ID: 31348267
[TBL] [Abstract][Full Text] [Related]
3. Treatment of hepatitis C in patients infected with human immunodeficiency virus in the direct-acting antiviral era.
Soriano V; Labarga P; Vispo E; Fernández-Montero JV; Barreiro P
Infect Dis Clin North Am; 2012 Dec; 26(4):931-48. PubMed ID: 23083825
[TBL] [Abstract][Full Text] [Related]
4. HCV-HIV co-infected patients: no longer a 'special' population?
Sulkowski MS
Liver Int; 2016 Jan; 36 Suppl 1():43-6. PubMed ID: 26725896
[TBL] [Abstract][Full Text] [Related]
5. HCV viral load at baseline and at week 4 of telaprevir/boceprevir based triple therapies are associated with virological outcome in HIV/hepatitis C co-infected patients.
Salmon D; Bani-Sadr F; Gilbert C; Rosenthal E; Valantin MA; Simon A; Neau D; Morlat P; Loko MA; Wittkop L; Dabis F;
J Clin Virol; 2015 Dec; 73():32-35. PubMed ID: 26528903
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Hepatitis C in HIV-Infected Patients: Moving Towards an Era of All Oral Regimens.
Chen TY; Jain MK
AIDS Patient Care STDS; 2015 Jun; 29(6):329-37. PubMed ID: 26020726
[TBL] [Abstract][Full Text] [Related]
7. Optimal therapy of HIV/HCV co-infected patients with direct acting antivirals.
Rockstroh JK
Liver Int; 2015 Jan; 35 Suppl 1():51-5. PubMed ID: 25529087
[TBL] [Abstract][Full Text] [Related]
8. Optimizing treatment in HIV/HCV coinfection.
Puoti M; Rossotti R; Travi G; Panzeri C; Morreale M; Chiari E; Cocca G; Orso M; Moioli MC
Dig Liver Dis; 2013 Sep; 45 Suppl 5():S355-62. PubMed ID: 24091116
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C Virus and Hepatitis B Virus Co-Infection.
Shih YF; Liu CJ
Viruses; 2020 Jul; 12(7):. PubMed ID: 32664198
[TBL] [Abstract][Full Text] [Related]
10. Editorial commentary: Management of hepatitis C Virus in HIV-infected patients in the era of direct-acting antivirals.
Zeremski M; Martinez AD; Talal AH
Clin Infect Dis; 2014 Mar; 58(6):880-2. PubMed ID: 24336913
[No Abstract] [Full Text] [Related]
11. Treating Hepatitis C in a Ryan White-Funded HIV Clinic: Has the Treatment Uptake Improved in the Interferon-Free Directly Active Antiviral Era?
Cope R; Glowa T; Faulds S; McMahon D; Prasad R
AIDS Patient Care STDS; 2016 Feb; 30(2):51-5. PubMed ID: 26744994
[TBL] [Abstract][Full Text] [Related]
12. Direct-acting Antivirals for HIV/HCV Co-infected Individuals: As Good as it Gets?
Bruno G; Saracino A
Curr HIV Res; 2017; 15(6):422-433. PubMed ID: 29119934
[TBL] [Abstract][Full Text] [Related]
13. Simeprevir for the treatment of hepatitis C and HIV/hepatitis C co-infection.
Flanagan S; Crawford-Jones A; Orkin C
Expert Rev Clin Pharmacol; 2014 Nov; 7(6):691-704. PubMed ID: 25209158
[TBL] [Abstract][Full Text] [Related]
14. HIV-hepatitis C virus co-infection in the era of direct-acting antivirals.
Bichoupan K; Dieterich DT; Martel-Laferrière V
Curr HIV/AIDS Rep; 2014 Sep; 11(3):241-9. PubMed ID: 24996617
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C direct-acting antiviral agents: changing the paradigm of hepatitis C treatment in HIV-infected patients.
Martel-Laferrière V; Bichoupan K; Dieterich DT
J Clin Gastroenterol; 2014 Feb; 48(2):106-12. PubMed ID: 24172182
[TBL] [Abstract][Full Text] [Related]
16. Treatment of hepatitis C in special populations.
Suda G; Ogawa K; Morikawa K; Sakamoto N
J Gastroenterol; 2018 May; 53(5):591-605. PubMed ID: 29299684
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms of IL28b gene as predictors of response to dual therapy in genotypes 1 and 4-HCV and HIV/HCV-infected patients.
Sticchi L; Di Biagio A; Sartini M; Rappazzo E; Nicolini LA; Cenderello G; Valle C; Azzola E; Grasso A; De Leo P; Boldrini A; Setti M; Prinapori R; Lorusso C; Bruzzone B; Icardi G;
New Microbiol; 2015 Oct; 38(4):499-509. PubMed ID: 26485009
[TBL] [Abstract][Full Text] [Related]
18. Management of acute and chronic HCV infection in persons with HIV coinfection.
Sulkowski MS
J Hepatol; 2014 Nov; 61(1 Suppl):S108-19. PubMed ID: 25443339
[TBL] [Abstract][Full Text] [Related]
19. Boceprevir and telaprevir-based regimens for the treatment of hepatitis C virus in HIV/HCV coinfected patients.
Beste LA; Green PK; Ioannou GN
Eur J Gastroenterol Hepatol; 2015 Feb; 27(2):123-9. PubMed ID: 25503739
[TBL] [Abstract][Full Text] [Related]
20. Therapy with boceprevir or telaprevir in HIV/hepatitis C virus co-infected patients to treat recurrence of hepatitis C virus infection after liver transplantation.
Antonini TM; Furlan V; Teicher E; Haim-Boukobza S; Sebagh M; Coilly A; Bonhomme-Faivre L; Roque-Afonso AM; Vittecoq D; Samuel D; Taburet AM; Duclos-Vallée JC
AIDS; 2015 Jan; 29(1):53-8. PubMed ID: 25387314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]